SEC Form SC 13G/A filed by CollPlant Biotechnologies Ltd (Amendment)

2/23/22 4:28:52 PM ET

$CLGN

Industrial Specialties

Health Care

Get the next $CLGN alert in real time by email

SC 13G/A 1 tm227455d1_sc13ga.htm SC 13G/A

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 3)*

CollPlant Biotechnologies Ltd.

(Name of Issuer)

Ordinary Shares, par value NIS 1.5 per share (including Ordinary Shares represented by American
Depositary Shares (ADSs) at a ratio of one Ordinary Share per each ADS)

(Title of Class of Securities)

19516R107

(CUSIP Number)

George Walter Loewenbaum Grantor Retained Annuity Trust I

George Walter Loewenbaum Grantor Retained Annuity Trust II

George Walter Loewenbaum Grantor Retained Annuity Trust V

Lillian S. Loewenbaum Grantor Retained Annuity Trust I

Lillian S. Loewenbaum Grantor Retained Annuity Trust IV

The Waterproof Partnership, Ltd.

The Loewenbaum 1992 Trust

George Walter Loewenbaum

Elizabeth S. Loewenbaum

Lillian S. Loewenbaum

c/o Lillian S. Loewenbaum

1000 Westbank Dr., Ste #2A

Austin, TX 78746

Copy to:

Jason R. Schendel

Sheppard, Mullin, Richter & Hampton LLP

Four Embarcadero Center

Embarcadero Ctr., 17th Floor

San Francisco, CA 94111

(650) 815-2600

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

December 31, 2021

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 19516R107

Page 2 of 19

1.	Name of Reporting Person: George Walter Loewenbaum
2.	Check the Appropriate Box if a Member of a Group	(a) ¨ (b) x
3.	SEC Use Only
4.	Citizenship or Place of Organization: United States of America

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power: 719,134 Ordinary Shares⁽¹⁾
	6.	Shared Voting Power: 0
	7.	Sole Dispositive Power: 719,134 Ordinary Shares⁽¹⁾
	8.	Shared Dispositive Power: 0

9.	Aggregate Amount Beneficially Owned by Each Reporting Person: 719,134 Ordinary Shares⁽¹⁾
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)	¨
11.	Percent of Class Represented by Amount in Row (9): 6.73%⁽²⁾
12.	Type of Reporting Person (See Instructions): IN

(1) Consists of (a) 60,000 shares of the Issuer’s ordinary shares underlying American Depository Shares (“ADSs”) held by the Walter Loewenbaum Trust, (b) 4,134 ordinary shares underlying ADSs held by the Reporting Person directly, and (c) 655,000 ordinary shares underlying ADSs held by the Reporting Person in an IRA.

(2) Based on 10,691,622 ordinary shares of the Issuer issued and outstanding as of September 30, 2021 (which number was set forth in the Report of Foreign Private Issuer on Form 6-K for the month of November 2021 filed with the SEC on November 18, 2021).

-2-

CUSIP No. 19516R107

Page 3 of 19

1.	Name of Reporting Person: Lillian S. Loewenbaum
2.	Check the Appropriate Box if a Member of a Group	(a) ¨ (b) x
3.	SEC Use Only
4.	Citizenship or Place of Organization: United States of America

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power: 34,381 Ordinary Shares⁽¹⁾
	6.	Shared Voting Power: 0
	7.	Sole Dispositive Power: 34,381 Ordinary Shares⁽¹⁾
	8.	Shared Dispositive Power: 0

9.	Aggregate Amount Beneficially Owned by Each Reporting Person: 34,381 Ordinary Shares⁽¹⁾
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)	¨
11.	Percent of Class Represented by Amount in Row (9): 0.32%⁽²⁾
12.	Type of Reporting Person (See Instructions): IN

(1) Consists of (a) 10,000 shares of the Issuer’s ordinary shares underlying ADSs held in the Lillian Shaw Loewenbaum Trust, and (b) 24,381 shares of the Issuer’s ordinary shares underlying ADSs held by the Reporting Person directly.

-3-

CUSIP No. 19516R107

Page 4 of 19

1.	Name of Reporting Person: Elizabeth S. Loewenbaum
2.	Check the Appropriate Box if a Member of a Group	(a) ¨ (b) x
3.	SEC Use Only
4.	Citizenship or Place of Organization: United States of America

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power: 10,000 Ordinary Shares
	6.	Shared Voting Power: 0
	7.	Sole Dispositive Power: 10,000 Ordinary Shares
	8.	Shared Dispositive Power: 0

9.	Aggregate Amount Beneficially Owned by Each Reporting Person: 10,000 Ordinary Shares
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)	¨
11.	Percent of Class Represented by Amount in Row (9): 0.09%⁽¹⁾
12.	Type of Reporting Person (See Instructions): IN

(1) Based on 10,691,622 ordinary shares of the Issuer issued and outstanding as of September 30, 2021 (which number was set forth in the Report of Foreign Private Issuer on Form 6-K for the month of November 2021 filed with the SEC on November 18, 2021).

-4-

CUSIP No. 19516R107

Page 5 of 19

1.	Name of Reporting Person: George Walter Loewenbaum Grantor Retained Annuity Trust I
2.	Check the Appropriate Box if a Member of a Group	(a) ¨ (b) x
3.	SEC Use Only
4.	Citizenship or Place of Organization: Texas

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power: 866 Ordinary Shares
	6.	Shared Voting Power: 0
	7.	Sole Dispositive Power: 866 Ordinary Shares
	8.	Shared Dispositive Power: 0

9.	Aggregate Amount Beneficially Owned by Each Reporting Person: 866 Ordinary Shares
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)	¨
11.	Percent of Class Represented by Amount in Row (9): 0.01%⁽¹⁾
12.	Type of Reporting Person (See Instructions): OO

-5-

CUSIP No. 19516R107

Page 6 of 19

1.	Name of Reporting Person: George Walter Loewenbaum Grantor Retained Annuity Trust II
2.	Check the Appropriate Box if a Member of a Group	(a) ¨ (b) x
3.	SEC Use Only
4.	Citizenship or Place of Organization: Texas

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power: 7,000 Ordinary Shares
	6.	Shared Voting Power: 0
	7.	Sole Dispositive Power: 7,000 Ordinary Shares
	8.	Shared Dispositive Power: 0

9.	Aggregate Amount Beneficially Owned by Each Reporting Person: 7,000 Ordinary Shares
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)	¨
11.	Percent of Class Represented by Amount in Row (9): 0.07%⁽¹⁾
12.	Type of Reporting Person (See Instructions): OO

-6-

CUSIP No. 19516R107

Page 7 of 19

1.	Name of Reporting Person: George Walter Loewenbaum Grantor Retained Annuity Trust V
2.	Check the Appropriate Box if a Member of a Group	(a) ¨ (b) x
3.	SEC Use Only
4.	Citizenship or Place of Organization: Texas

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power: 13,078 Ordinary Shares
	6.	Shared Voting Power: 0
	7.	Sole Dispositive Power: 13,078 Ordinary Shares
	8.	Shared Dispositive Power: 0

9.	Aggregate Amount Beneficially Owned by Each Reporting Person: 13,078 Ordinary Shares
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)	¨
11.	Percent of Class Represented by Amount in Row (9): 0.12%⁽¹⁾
12.	Type of Reporting Person (See Instructions): OO

-7-

CUSIP No. 19516R107

Page 8 of 19

1.	Name of Reporting Person: Lillian S. Loewenbaum Grantor Retained Annuity Trust I
2.	Check the Appropriate Box if a Member of a Group	(a) ¨ (b) x
3.	SEC Use Only
4.	Citizenship or Place of Organization: Texas

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power: 2,046 Ordinary Shares
	6.	Shared Voting Power: 0
	7.	Sole Dispositive Power: 2,046 Ordinary Shares
	8.	Shared Dispositive Power: 0

9.	Aggregate Amount Beneficially Owned by Each Reporting Person: 2,046 Ordinary Shares
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)	¨
11.	Percent of Class Represented by Amount in Row (9): 0.02%⁽¹⁾
12.	Type of Reporting Person (See Instructions): OO

-8-

CUSIP No. 19516R107

Page 9 of 19

1.	Name of Reporting Person: Lillian S. Loewenbaum Grantor Retained Annuity Trust IV
2.	Check the Appropriate Box if a Member of a Group	(a) ¨ (b) x
3.	SEC Use Only
4.	Citizenship or Place of Organization: Texas

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power: 54,000 Ordinary Shares
	6.	Shared Voting Power: 0
	7.	Sole Dispositive Power: 54,000 Ordinary Shares
	8.	Shared Dispositive Power: 0

9.	Aggregate Amount Beneficially Owned by Each Reporting Person: 54,000 Ordinary Shares
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)	¨
11.	Percent of Class Represented by Amount in Row (9): 0.51%⁽¹⁾
12.	Type of Reporting Person (See Instructions): OO

-9-

CUSIP No. 19516R107

Page 10 of 19

1.	Name of Reporting Person: The Loewenbaum 1992 Trust
2.	Check the Appropriate Box if a Member of a Group	(a) ¨ (b) x
3.	SEC Use Only
4.	Citizenship or Place of Organization: Texas

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power: 34,000 Ordinary Shares
	6.	Shared Voting Power: 0
	7.	Sole Dispositive Power: 34,000 Ordinary Shares
	8.	Shared Dispositive Power: 0

9.	Aggregate Amount Beneficially Owned by Each Reporting Person: 34,000 Ordinary Shares
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)	¨
11.	Percent of Class Represented by Amount in Row (9): 0.32%⁽¹⁾
12.	Type of Reporting Person (See Instructions): OO

-10-

CUSIP No. 19516R107

Page 11 of 19

1.	Name of Reporting Person: The Waterproof Partnership, Ltd.
2.	Check the Appropriate Box if a Member of a Group	(a) ¨ (b) x
3.	SEC Use Only
4.	Citizenship or Place of Organization: Texas

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power: 29,000 Ordinary Shares
	6.	Shared Voting Power: 0
	7.	Sole Dispositive Power: 29,000 Ordinary Shares
	8.	Shared Dispositive Power: 0

9.	Aggregate Amount Beneficially Owned by Each Reporting Person: 29,000 Ordinary Shares
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)	¨
11.	Percent of Class Represented by Amount in Row (9): 0.27%⁽¹⁾
12.	Type of Reporting Person (See Instructions): OO

-11-

CUSIP No. 19516R107

Page 12 of 19

Item 1(a).

Name of Issuer:

CollPlant Biotechnologies Ltd. (the “Issuer”)

Item 1(b).

Address of Issuer’s Principal Executive Offices:

4 Oppenheimer St, Weizmann Science Park

Rehovot 7670104, Israel

Item 2(a).

Name of Person(s) Filing:

This statement is filed by the individuals and entities listed below, all of whom together are referred to herein as the “Reporting Persons”.

(i) George Walter Loewenbaum, an individual

(ii) Lillian S. Loewenbaum, an individual

(iii) Elizabeth Loewenbaum, an individual

(iv) George Walter Loewenbaum Grantor Retained Annuity Trust I, a Texas trust

(v) George Walter Loewenbaum Grantor Retained Annuity Trust II, a Texas trust

(vi) George Walter Loewenbaum Grantor Retained Annuity Trust V, a Texas trust,

(vii) Lillian S. Loewenbaum Grantor Retained Annuity Trust I, a Texas trust,

(viii) Lillian S. Loewenbaum Grantor Retained Annuity Trust IV, a Texas trust,

(ix) The Loewenbaum 1992 Trust, a Texas trust, and

(x) The Waterproof Partnership, Ltd., a Texas partnership.

Item 2(b).

Address of Principal Business Office or, if none, Residence:

The address of the principal business office of each Reporting Person is 1000 Westbank Dr, Ste #2A, Austin, TX 78746.

Item 2(c).

Citizenship:

See Item 4 of each cover page.

Item 2(d).

Title of Class of Securities:

See the cover page of this filing.

Item 2(e).

CUSIP Number:

19516R107.

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable.

-12-

CUSIP No. 19516R107

Page 13 of 19

Item 4.

Ownership.

(a)            Amount beneficially owned:

See Item 9 of each cover page.

(b)

Percent of class:

See Item 11 of each cover page.

(c)

Number of shares as to which the person has:

(i)            Sole power to vote or to direct the vote:

See Item 5 of each cover page.

(ii)           Shared power to vote or to direct the vote:

See Item 6 of each cover page.

(iii)          Sole power to dispose or to direct the disposition of:

See Item 7 of each cover page.

(iv)          Shared power to dispose or to direct the disposition of:

See Item 8 of each cover page.

Item 5.

Ownership of Five Percent or Less of a Class.

If the statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not applicable.

Item 8.

Identification and Classification of Members of the Group.

Not applicable.

-13-

CUSIP No. 19516R107

Page 14 of 19

Item 9.

Notice of Dissolution of Group.

Not applicable.

Item 10.

Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

-14-

CUSIP No. 19516R107

Page 15 of 19

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated:	February 23, 2022	Name:	/s/ George Walter Loewenbaum

Dated:	February 23, 2022	Name:	/s/ Lillian S. Loewenbaum

Dated:	February 23, 2022	Name:	/s/ Elizabeth Loewenbaum

Dated:	February 23, 2022	George Walter Loewenbaum Grantor Retained Annuity Trust I

		By:	/s/ George Walter Loewenbaum
		Name:	George Walter Loewenbaum
		Title:	Trustee

Dated:	February 23, 2022	George Walter Loewenbaum Grantor Retained Annuity Trust II

		By:	/s/ George Walter Loewenbaum
		Name:	George Walter Loewenbaum
		Title:	Trustee

Dated:	February 23, 2022	George Walter Loewenbaum Grantor Retained Annuity Trust V

		By:	/s/ George Walter Loewenbaum
		Name:	George Walter Loewenbaum
		Title:	Trustee

Dated:	February 23, 2022	Lillian S. Loewenbaum Grantor Retained Annuity Trust I

		By:	/s/ George Walter Loewenbaum
		Name:	George Walter Loewenbaum
		Title:	Trustee

Dated:	February 23, 2022	Lillian S. Loewenbaum Grantor Retained Annuity Trust IV

		By:	/s/ George Walter Loewenbaum
		Name:	George Walter Loewenbaum
		Title:	Trustee

Dated:	February 23, 2022	The Waterproof Partnership, Ltd.

		By:	/s/ George Walter Loewenbaum
		Name:	George Walter Loewenbaum
		Title:	General Partner

		By:	/s/ Lillian S. Loewenbaum
		Name:	S. Loewenbaum
		Title:	General Partner

-15-

CUSIP No. 19516R107

Page 16 of 19

Dated:	February 23, 2022	The Loewenbaum 1992 Trust

		By:	/s/ George Walter Loewenbaum
		Name:	George Walter Loewenbaum
		Title:	Trustee

		By:	/s/ Lillian S. Loewenbaum
		Name:	Lillian S. Loewenbaum
		Title:	Trustee

-16-

CUSIP No. 19516R107

Page 17 of 19

EXHIBIT INDEX

Exhibit

Exhibit A:       Joint Filing Agreement.

-17-

CUSIP No. 19516R107

Page 18 of 19

EXHIBIT A

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Ordinary Shares, par value NIS 1.5 per share (including Ordinary Shares represented by American Depositary Shares (ADSs) at a ratio of one Ordinary Share per ADS, of CollPlant Biotechnologies Ltd., and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filings.

The undersigned further agree that each party hereto is responsible for the timely filing of such Statement on Schedule 13G and any amendments thereto, and for the accuracy and completeness of the information concerning such party contained therein; provided, however, that no party is responsible for the accuracy or completeness of the information concerning any other party, unless such party knows or has reason to believe that such information is inaccurate.

This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of February 23, 2022.

Dated:	February 23, 2022	Name:	/s/ George Walter Loewenbaum

Dated:	February 23, 2022	Name:	/s/ Lillian S. Loewenbaum

Dated:	February 23, 2022	Name:	/s/ Elizabeth Loewenbaum

Dated:	February 23, 2022	George Walter Loewenbaum Grantor Retained Annuity Trust I

		By:	/s/ George Walter Loewenbaum
		Name:	George Walter Loewenbaum
		Title:	Trustee

Dated:	February 23, 2022	George Walter Loewenbaum Grantor Retained Annuity Trust II

		By:	/s/ George Walter Loewenbaum
		Name:	George Walter Loewenbaum
		Title:	Trustee

Dated:	February 23, 2022	George Walter Loewenbaum Grantor Retained Annuity Trust V

		By:	/s/ George Walter Loewenbaum
		Name:	George Walter Loewenbaum
		Title:	Trustee

Dated:	February 23, 2022	Lillian S. Loewenbaum Grantor Retained Annuity Trust I

		By:	/s/ George Walter Loewenbaum
		Name:	George Walter Loewenbaum
		Title:	Trustee

-18-

CUSIP No. 19516R107

Page 19 of 19


Dated:	February 23, 2022	Lillian S. Loewenbaum Grantor Retained Annuity Trust IV

		By:	/s/ George Walter Loewenbaum
		Name:	George Walter Loewenbaum
		Title:	Trustee

Dated:	February 23, 2022	The Waterproof Partnership, Ltd.

		By:	/s/ George Walter Loewenbaum
		Name:	George Walter Loewenbaum
		Title:	General Partner

		By:	/s/ Lillian S. Loewenbaum
		Name:	Lillian S. Loewenbaum
		Title:	General Partner

Dated:	February 23, 2022	The Loewenbaum 1992 Trust

		By:	/s/ George Walter Loewenbaum
		Name:	George Walter Loewenbaum
		Title:	Trustee

		By:	/s/ Lillian S. Loewenbaum
		Name:	Lillian S. Loewenbaum
		Title:	Trustee

-19-

Get the next $CLGN alert in real time by email

SEC Form SC 13G/A filed by CollPlant Biotechnologies Ltd (Amendment)

Chat with this insight

Recent Analyst Ratings for
$CLGN

$CLGN
SEC Filings

SEC Form 6-K filed by CollPlant Biotechnologies Ltd

SEC Form 20-F filed by CollPlant Biotechnologies Ltd

SEC Form 6-K filed by CollPlant Biotechnologies Ltd

$CLGN
Leadership Updates

Live Leadership Updates

Enlivex Appoints Dr. Roger J. Pomerantz to its Board of Directors as Vice Chairman

RION Appoints Alisa Lask as Chief Commercial Officer

CollPlant Appoints Medical Aesthetics Veteran Alisa Lask to Board of Directors

$CLGN
Press Releases

Fastest customizable press release news feed in the world

CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

$CLGN
Financials

Live finance-specific insights

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

$CLGN
Large Ownership Changes

This live feed shows all institutional transactions in real time.